Acelyrin, Inc. (SLRN)
| Market Cap | 726.15M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -306.24M |
| Shares Out | 97.34M |
| EPS (ttm) | -4.29 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 848,335 |
| Open | 7.64 |
| Previous Close | 7.63 |
| Day's Range | 7.23 - 7.64 |
| 52-Week Range | 5.77 - 29.88 |
| Beta | n/a |
| Analysts | Buy |
| Price Target | 23.67 (+217.29%) |
| Earnings Date | Feb 8, 2024 |
About SLRN
Acelyrin, Inc., a clinical biopharma company, focuses on identifying, acquiring, and accelerating the development and commercialization of transformative medicines. The company's lead product candidate is izokibep, a small protein therapeutic designed to inhibit IL-17A with high potency, which is in Phase 3 clinical trials for use in the treatment of Hidradenitis Suppurativa, Psoriatic Arthritis, and uveitis, as well as in Phase 2 clinical trials for use in the treatment of Axial Spondyloarthritis. It is also developing lonigutamab, a humanized... [Read more]
Financial Performance
Financial StatementsAnalyst Forecast
According to 7 analysts, the average rating for SLRN stock is "Buy." The 12-month stock price forecast is $23.67, which is an increase of 217.29% from the latest price.
News
SLRN CLASS ACTION ANNOUNCEMENT: Kessler Topaz Meltzer & Check, LLP Announces Securities Class Action Lawsuit Filed Against Acelyrin, Inc. (SLRN)
RADNOR, Pa. , Dec. 29, 2023 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been against Acelyrin, Inc. ...
IMPORTANT DEADLINE REMINDER: The Schall Law Firm Encourages Investors in Acelyrin, Inc. with Losses to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / December 29, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Acelyrin, Inc. ("Acelyrin" or...
ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Acelyrin, Inc. of Class Action Lawsuit and Upcoming Deadline - SLRN
NEW YORK , Dec. 28, 2023 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Acelyrin, Inc. ("Acelyrin" or the "Company") (NASDAQ: SLRN) and certain officers. Th...
SLRN Investors Have Opportunity to Lead ACELYRIN, Inc. Securities Fraud Lawsuit
LOS ANGELES , Dec. 28, 2023 /PRNewswire/ -- Glancy Prongay & Murray LLP ("GPM") announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit agai...
ACELYRIN INVESTOR DEADLINE APPROACHING : Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Acelyrin To Contact Him Directly To Discuss Their Options
If you suffered losses exceeding $50,000 investing in Acelyrin securities between May 4, 2023 and September 11, 2023 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wils...
SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Acelyrin, Inc. with Losses of $100,000 to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / December 28, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Acelyrin, Inc. ("Acelyrin" or...
SHAREHOLDER ALERT: Levi & Korsinsky Notifies Acelyrin, Inc.(SLRN) Investors of a Class Action Lawsuit and Upcoming Deadline
NEW YORK , Dec. 27, 2023 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Acelyrin, Inc. ("Acelyrin" or the "Company") (NASDAQ: SLRN) of a class action securities lawsuit. CLASS DEFINITION:...
INVESTOR ACTION ALERT: The Schall Law Firm Encourages Investors in Acelyrin, Inc. with Losses to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / December 26, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Acelyrin, Inc. ("Acelyrin" or...
ROSEN, A LONGSTANDING LAW FIRM, Encourages ACELYRIN, INC. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SLRN
NEW YORK , Dec. 23, 2023 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of ACELYRIN, INC. (NASDAQ: SLRN) between May 4, 2023 and September 11,...
FINAL DEADLINE APPROACHING: The Schall Law Firm Encourages Investors in Acelyrin, Inc. with Losses to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / December 22, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Acelyrin, Inc. ("Acelyrin" or...
ACELYRIN INVESTOR DEADLINE APPROACHING: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Acelyrin To Contact Him Directly To Discuss Their Options
If you suffered losses exceeding $50,000 investing in Acelyrin securities between May 4, 2023 and September 11, 2023 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wils...
DEADLINE ACTION NOTICE: The Schall Law Firm Encourages Investors in Acelyrin, Inc. with Losses to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / December 21, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Acelyrin, Inc. ("Acelyrin" or...
ACELYRIN, INC. Appoints Lynn Tetrault to Board of Directors
Former Executive Vice President of Human Resources and Corporate Affairs at AstraZeneca PLC brings more than 30 years of strategic expertise in human resources, business operations, and corporate affa...
Attention SLRN Shareholders: Kessler Topaz Meltzer & Check, LLP Reminds Shareholders of Securities Fraud Class Action Lawsuit Filed against Acelyrin, Inc. (SLRN) and Encourages Investors to Contact the Firm
RADNOR, Pa. , Dec. 20, 2023 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been against Acelyrin, Inc. (...
INVESTOR ACTION NOTICE: The Schall Law Firm Encourages Investors in Acelyrin, Inc. with Losses to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / December 19, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Acelyrin, Inc. ("Acelyrin" or...
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in ACELYRIN, Inc. of Class Action Lawsuit and Upcoming Deadline - SLRN
NEW YORK , Dec. 18, 2023 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against ACELYRIN, Inc. ("Acelyrin" or the "Company") (NASDAQ: SLRN) and certain officers. ...
SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Acelyrin, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 16, 2024 - (NASDAQ: SLRN)
NEW YORK , Dec. 18, 2023 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Acelyrin, Inc.. Shareholders who purchased shares of SLRN during the class period listed are ...
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages ACELYRIN, INC. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SLRN
NEW YORK , Dec. 17, 2023 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of ACELYRIN, INC. (NASDAQ: SLRN) between May 4, 2023 and September 11,...
DiCello Levitt LLP Announces Investor Class Action Lawsuit Filed Against Acelyrin, Inc. (NASDAQ: SLRN) and Lead Plaintiff Deadline
SAN DIEGO , Dec. 12, 2023 /PRNewswire/ -- DiCello Levitt LLP announces that purchasers or acquirers of ACELYRIN, Inc. ("Acelyrin" or the "Company" – NYSE: SLRN) securities between May 4, 2023 and Sept...
ROSEN, NATIONAL INVESTOR COUNSEL, Encourages ACELYRIN, INC. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SLRN
NEW YORK , Dec. 11, 2023 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of ACELYRIN, INC. (NASDAQ: SLRN) between May 4, 2023 and September 11...
Kessler Topaz Meltzer & Check, LLP Reminds Acelyrin, Inc. Investors of Important Deadline in Securities Fraud Class Action Lawsuit and Encourages Investors with Substantial Losses to Contact the Firm
RADNOR, Pa. , Dec. 11, 2023 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been against Acelyrin, Inc. (...
IMPORTANT DEADLINE NOTICE: The Schall Law Firm Encourages Investors in Acelyrin, Inc. with Losses to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / December 11, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Acelyrin, Inc. ("Acelyrin" or...
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Acelyrin, Inc. of Class Action Lawsuit and Upcoming Deadline - SLRN
NEW YORK , Dec. 10, 2023 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Acelyrin, Inc. ("Acelyrin" or the "Company") (NASDAQ: SLRN) and certain officers. Th...
INVESTOR ACTION ALERT: The Schall Law Firm Encourages Investors in Acelyrin, Inc. with Losses of $100,000 to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / December 7, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Acelyrin, Inc. ("Acelyrin" or ...
FINAL DEADLINE REMINDER: The Schall Law Firm Encourages Investors in Acelyrin, Inc. with Losses of $100,000 to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / December 6, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Acelyrin, Inc. ("Acelyrin" or ...